Successful FDA Inspection of our Bioanalytical Laboratory
Pharmascience Inc. Launches (Pr)pms-NITROFURANTOIN, First Generic Bioequivalent to MacroBID® Available on the Market, for the Treatment of Urinary Tract Infections
Pendopharm a division of Pharmascience signs an agreement with Cosmo Pharmaceuticals
